The landscape of diabetes care is evolving with the emergence of transdermal GLP-1 delivery . These novel patches offer a likely simpler alternative to shots for individuals living with diabetes mellitus type 2 . They deliver glucagon-like peptide-1 directly through the dermis , circumventing the